Register
FDA Issues First Emergency Use Authorization for Point of Care Diagnostic for COVID-19 |
Clinical News
eMediNexus Coverage from: 
FDA Issues First Emergency Use Authorization for Point of Care Diagnostic for COVID-19

1 Read Comments                

The U.S. Food and Drug Administration has issued the first emergency use authorization for a point-of-care COVID-19 diagnostic for the Cepheid Xpert Xpress SARS-CoV-2 test.

The test will provide Americans with results within hours, rather than days like the currently used tests. It is expected to be rolled out by March 30… (FDA, March 21, 2020)

To comment on this article,
create a free account.
Sign Up to instantly read 30000+ free Articles & 1000+ Case Studies
Create Account

Already registered?

Login Now